Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

222

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

May 31, 2015

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

evogliptin

evogliptin 5mg tablet qd + placebo tablet matching to sitagliptin 100mg

DRUG

Sitagliptin

sitagliptin 100 mg tablet qd + placebo tablet matching to evogliptin 5mg

Trial Locations (1)

Kangbuk Samsung Medical Center, Seoul

All Listed Sponsors

lead

Dong-A ST Co., Ltd.

INDUSTRY

NCT02949193 - Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 Diabetes | Biotech Hunter | Biotech Hunter